Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cyclin alterations in diverse cancers: Outcome and co-amplification network.

Oncotarget - 20 Feb 2015

Schwaederlé Maria, Daniels Gregory A, Piccioni David E, Fanta Paul T, Schwab Richard B, Shimabukuro Kelly A, Parker Barbara A, Kurzrock Razelle

Abstract excerpt

Cyclin genes are key regulatory components of the cell cycle. With the development of new agents, cyclin-related genes are becoming increasingly important as they can be targeted. Yet, the biological implications of these alterations have not been fully studied. Clinical characteristics and outcome parameters were compared for patients harboring cyclin alterations versus not. CCN alterations were found in 13% of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclins
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Amplification

Share to Gene Regulatory Networks

Share to Kaplan-Meier Estimate

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Proportional Hazards Models

Source

Open in PubMed Open full text

Identifiers

PMID: 25596748
DOI: 10.18632/oncotarget.2848
PMCID: PMC4413635

Genes

ARFRP1
MET
PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cyclin alterations in diverse cancers: Outcome and co-amplification network.PMID 25596748Read ↗

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions.Semantic proximity Read ↗

Concomitant MEK and Cyclin Gene Alterations: Implications for Response to Targeted Therapeutics.Semantic proximity Read ↗

Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristicsSemantic proximity Read ↗

Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and StromaSemantic proximity Read ↗

Integrative multi-omics analysis reveals the landscape of Cyclin-Dependent Kinase (CDK) family genes in pan-cancerSemantic proximity Read ↗

Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences.Semantic proximity Read ↗

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcomeSemantic proximity Read ↗

Coming of Age: Targeting Cyclin K in CancersSemantic proximity Read ↗

Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and presentSemantic proximity Read ↗

Molecular Landscape of TP53/RB1 Co-Altered Tumors Uncovers Emerging Therapeutic Vulnerabilities.Semantic proximity Read ↗

Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumorsSemantic proximity Read ↗

CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilitiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.